EUVIMEDEUVIMED entdecken
Crossref

lncRNA GMDS-AS1 Restrains Lung Adenocarcinoma Progression Via Recruiting TAF15 Protein to Stabilize SIRT1 mRNA

Wei Peng iD, Junjie Jiang iD, Jia Fu iD, Huaxin Duan iD, Jia Wang iD, Chaojun Duan iD

Epigenomics · 2023

DOI: 10.2217/epi-2022-0432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epigenomics, 2023. Verfasst von Wei Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Human Normal University, Changsha, Hunan, 410005, P.R. C…. Hauptthemen laut MEDLINE: Adenocarcinoma, Lung Neoplasms, MicroRNAs, RNA, Long Noncoding. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Outstanding Youth Program of Hunan Provincial Department of Education, Changsha Natural Science Foundation, Hunan Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To explore the roles of GMDS-AS1 in the epithelial-mesenchymal transition (EMT) of lung adenocarcinoma (LUAD). Materials & methods: Cell functions were detected by flow cytometry, cell counting kit-8, wound healing assays and transwell assays. RNA immunoprecipitation and pull-down assays were applied for determining the interaction among GMDA-AS1, TAF15 and SIRT1. A subcutaneous xenograft model was established.

Results

GMDS-AS1 downregulation was associated with poor survival of LUAD patients. GMDS-AS1 repressed malignant phenotypes, tumor growth and EMT in vitro and in vivo. Mechanically, GMDS-AS1 recruited TAF15 protein to stabilize SIRT1 mRNA and thereby deacetylated p65 and reduced the recruitment of p65 to MMP-9 promoter, thus inhibiting MMP-9 expression.

Conclusion

GMDS-AS1 represses EMT by recruiting TAF15 protein to stabilize SIRT1 mRNA and deacetylate p65, thus restraining LUAD progression. GMDS-AS1, a novel lncRNA, is involved in the progression of lung adenocarcinoma (LUAD), but the mechanism by which GMDS-AS1 regulates LUAD progression remains largely unknown. This study found that GMDS-AS1 was downregulated in LUAD patients, and its low expression was associated with advanced metastasis and poor survival. Overexpression of GMDS-AS1 significantly impaired tumor cell viability, proliferation, migration, invasion and epithelial–mesenchymal transition but enhanced apoptosis. In addition, GMDS-AS1 repressed tumor growth in mice. GMDS-AS1 functioned as a tumor suppressor in LUAD by recruiting TAF15 protein to stabilize SIRT1 mRNA and deacetylate p65, thus decreasing the recruitment of p65 to MMP-9 promoter. These findings have uncovered a novel mechanism underlying LUAD progression and suggested potential prognostic biomarkers and therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaLung NeoplasmsMicroRNAsRNA, Long NoncodingTATA-Binding Protein Associated FactorsHumansCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticLungMatrix Metalloproteinase 9Sirtuin 1Animals

Stichwörter der Autor:innen

EMTGMDS-AS1SIRT1TAF15acetylationlung adenocarcinomap65

Substanzen

Matrix Metalloproteinase 9MicroRNAsRNA, Long NoncodingSIRT1 protein, humanSirtuin 1TAF15 protein, humanTATA-Binding Protein Associated Factors

Autor:innen und Institutionen

  • Department of Oncology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Human Normal University, Changsha, Hunan, 410005, P.R. China.
  • Key Laboratory of Study & Discovery of Small Targeted Molecules of Hunan Province, Hunan Normal University, Changsha, Hunan, 410013, P.R. China.
  • Laboratory of Oncology, Institute of Translational Medicine, Hunan Provincial People's Hospital, Changsha, Hunan, 410005, P.R. China.
  • Institute of Medical Sciences, Xiangya Hospital, Central South University, Xiangya Road 87th, Changsha, Hunan, 410008, P.R. China.
  • Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Xiangya Road 87th, Changsha, Hunan, 410008, P.R. China.
  • Hunan Provincial People's Hospital, The First Affiliated Hospital of Human Normal University, Changsha, Hunan, 410005, P.R. China.

ORCID-Profile: Wei Peng, Junjie Jiang, Jia Fu, Huaxin Duan, Jia Wang, Chaojun Duan

Förderung

  • Outstanding Youth Program of Hunan Provincial Department of Education
  • Changsha Natural Science Foundation
  • Hunan Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Peng, W., Jiang, J., Fu, J., Duan, H., Wang, J., & Duan, C. (2023). lncRNA GMDS-AS1 Restrains Lung Adenocarcinoma Progression Via Recruiting TAF15 Protein to Stabilize SIRT1 mRNA. Epigenomics. https://doi.org/10.2217/epi-2022-0432

Vancouver

Peng W, Jiang J, Fu J, Duan H, Wang J, Duan C. lncRNA GMDS-AS1 Restrains Lung Adenocarcinoma Progression Via Recruiting TAF15 Protein to Stabilize SIRT1 mRNA. Epigenomics. 2023. doi:10.2217/epi-2022-0432

BibTeX
@article{Peng2023,
  author = {Peng, Wei and Jiang, Junjie and Fu, Jia and Duan, Huaxin and Wang, Jia and Duan, Chaojun},
  title = {lncRNA GMDS-AS1 Restrains Lung Adenocarcinoma Progression Via Recruiting TAF15 Protein to Stabilize SIRT1 mRNA},
  journal = {Epigenomics},
  year = {2023},
  doi = {10.2217/epi-2022-0432}
}
Kostenlos starten →